Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial

Alzheimers Dement. 2023 Jan;19(1):285-295. doi: 10.1002/alz.12630. Epub 2022 Apr 2.

Abstract

Introduction: Empirical studies on effective communication for amyloid disclosure in mild cognitive impairment (MCI) are lacking. We aimed to study the impact of six communication strategies.

Method: We performed a randomized controlled trial with seven randomly assigned, video-vignette conditions: six emphasizing a communication strategy and one basic condition. All showed a scripted consultation of a neurologist disclosing positive amyloid positron emission tomography (PET) scan results to an MCI patient. Healthy individuals (N = 1017; mean age ± SD 64 ± 8, 808 (79%) female) were instructed to imagine themselves in the video, answered questionnaires assessing information recall, emotional state, and behavioral intentions, and evaluate the physician/information.

Results: "Risk best practice" resulted in highest free recall compared to other strategies (P < .05), except "emotional support". Recall in "emotional support" was better compared to "basic-' and elaborate information"(P < .05). "Risk best practice" resulted in the highest uncertainty (P < .001). "Teach-back" and "emotional support" contributed to the highest evaluations (P -values < .01).

Conclusion: Risk communication best practices, attending to emotions, and teach-back techniques enhance information recall of amyloid-PET results, and could contribute to positive care evaluations.

Keywords: MCI; amyloid status; communication; disclosure; mild cognitive impairment.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / psychology
  • Amyloid*
  • Amyloidogenic Proteins
  • Cognitive Dysfunction* / diagnostic imaging
  • Cognitive Dysfunction* / psychology
  • Communication
  • Disclosure
  • Emotions
  • Female
  • Humans
  • Male
  • Mental Recall
  • Middle Aged
  • Positron-Emission Tomography
  • Truth Disclosure*

Substances

  • Amyloid
  • Amyloidogenic Proteins